SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-18-006148
Filing Date
2018-08-02
Accepted
2018-08-02 06:19:07
Documents
60
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 6-K argx-20180831x6k.htm 6-K 33307
2 EX-99.1 argx-20180831ex991468876.htm EX-99.1 125534
3 EX-99.2 argx-20180831ex9922739d1.htm EX-99.2 1379478
4 GRAPHIC argx20180831ex991468876001.jpg GRAPHIC 3224
5 GRAPHIC argx20180831ex991468876002.jpg GRAPHIC 3225
  Complete submission text file 0001558370-18-006148.txt   6617774

Data Files

Seq Description Document Type Size
6 EX-101.INS argx-20180831.xml EX-101.INS 1654912
7 EX-101.SCH argx-20180831.xsd EX-101.SCH 66935
8 EX-101.CAL argx-20180831_cal.xml EX-101.CAL 55316
9 EX-101.DEF argx-20180831_def.xml EX-101.DEF 146448
10 EX-101.LAB argx-20180831_lab.xml EX-101.LAB 396429
11 EX-101.PRE argx-20180831_pre.xml EX-101.PRE 289493
Mailing Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZQIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 18986528
SIC: 2836 Biological Products, (No Diagnostic Substances)